Stoke Therapeutics to Present at the UBS Global Healthcare Virtual Conference

by Business Wire • 2021/05/18 • 0 Comments

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021, at 5:00 p.m. ET. A live audio webcast of the presentation, which will be conducted in fireside chat format, will be availa

Subconjunctival sirolimus-loaded liposomes may be effective in dry eye disease →

Post navigation